Earnings Feed
Start Free
Home/Filings/4/0001246360-17-002020
4//SEC Filing

NxStage Medical, Inc. 4

Accession 0001246360-17-002020

CIK 0001333170operating
View on SEC.govCompany Profile

Filed

May 25, 8:00 PM ET

Accepted

May 26, 3:21 PM ET

Size

8.7 KB

Accession

0001246360-17-002020

Insider Transaction Report

Form 4
Period: 2017-04-20
NxStage Medical, Inc.NXTM
Donigan Heyward R
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2017-04-20$21.73/sh+3,582$77,837→ 3,582 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2017-04-20−3,582→ 10,784 total
    Exercise: $21.73From: 2016-08-15Exp: 2023-07-14→ Common Stock (3,582 underlying)
  • Award

    Stock Option (Right to Buy)

    2017-05-25+15,643→ 15,643 total
    Exercise: $22.78From: 2017-06-25Exp: 2024-05-24→ Common Stock (15,643 underlying)
Footnotes (1)
  • [F1]The stock option becomes exercisable in 12 equal monthly installments beginning June 25, 2017.

Documents

1 file

Issuer

NxStage Medical, Inc.

CIK 0001333170

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001333170

Filing Metadata

Form type
4
Filed
May 25, 8:00 PM ET
Accepted
May 26, 3:21 PM ET
Size
8.7 KB
View on SEC.gov